AGT and triple-A syndrome: For the AngII No AAA cohort, average CCS was reduced (−47.1% ± 20.7%; p < 0.05) compared to the Saline cohort and was 59.8 ± 39.8% higher (p < 0.05) than that for the AngII AAA cohort.